← Human Trials & Peer-Reviewed Studies
Comparison of Preoperative Topical Magnesium Sulfate Spraying and Magnesium Sulfate Gargling for the Prevention of Postoperative Sore Throat after Tracheal Intubation: A Randomized, Double-Blind, Non-Inferiority Trial.
Plain-language guide to PMID 40098904 (2025): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 236 participants.
Key Facts
- PMID
- 40098904
- Journal
- Drug design, development and therapy
- Year
- 2025
- Study type
- Randomized Controlled Trial
- Authors
- Wang L et al. (6 authors)
- DOI
- 10.2147/DDDT.S502081
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Who Took Part
The abstract describes 236 participants taking part.
PubMed indexes the participants as adults and middle-aged adults, both men and women.
236 Participants were randomly allocated to either the magnesium sulfate spray group (Group A) or the magnesium sulfate gargle group (Group B), with 118 patients in each group.
How the Study Was Run
The researchers set it up as a randomized and double-blind study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
What Was Measured
Topics PubMed links to this paper include Administration, Topical, Intubation, Intratracheal, Magnesium Sulfate, Pharyngitis and Postoperative Complications.
The authors tagged it with the keywords endotracheal intubation, general anaesthesia and postoperative sore throat.
What This Means in Plain Language
The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc in 236 participants.
The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2025 (Drug design, development and therapy), a journal based in New Zealand.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.